Science News
from research organizations
This simple amino acid supplement greatly reduces Alzheimer’s damage
A common, low-cost amino acid could become an unexpected new weapon against Alzheimer’s.
Date:
May 4, 2026
Source:
Kindai University
Summary:
A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of toxic amyloid proteins in the brain, a hallmark of the disease. In animal models, oral arginine not only lowered harmful protein deposits but also improved behavior and reduced brain inflammation.
Share:
Facebook
Twitter
Pinterest
LinkedIN
Email
FULL STORY
A simple amino acid called arginine may help slow Alzheimer’s by blocking toxic protein buildup and reducing brain inflammation. Credit: Shutterstock
Alzheimer's disease (AD) is a progressive brain disorder and a leading cause of dementia worldwide. Despite years of research, there is still no cure. New antibody-based treatments that target amyloid β (Aβ) have recently emerged, but their benefits have been modest. These therapies can also be expensive and may trigger immune-related side effects, underscoring the urgent need for safer, more affordable options that can slow the disease.
A recent study published in
Neurochemistry International
offers a surprising possibility. Researchers from Kindai University and partner institutions found that arginine, a naturally occurring amino acid, can reduce the buildup of harmful Aβ proteins in animal models of Alzheimer's. Arginine also acts as a safe chemical chaperone, helping proteins maintain their proper structure.
The team noted that while arginine is widely available as an over-the-counter supplement, the doses and methods used in this study were specifically designed for research and are not the same as commercial products.
The research group included Graduate Student Kanako Fujii and Professor Yoshitaka Nagai from the Department of Neurology at Kindai University Faculty of Medicine in Osaka, along with Associate Professor Toshihide Takeuchi from the Life Science Research Institute at Kindai University.
Lab and Animal Studies Show Strong Effects
In laboratory experiments, the scientists first showed that arginine can block the formation of Aβ42 aggregates, which are considered especially toxic. The effect increased with higher concentrations.
They then tested oral arginine in two well-established Alzheimer's models:
A Drosophila model, expressing Aβ42 with the Arctic mutation (E22G)
An
App
NL-G-F
knock-in mouse model, carrying three familial AD mutations
In both cases, arginine treatment reduced the accumulation of Aβ and lessened its harmful effects.
"Our study demonstrates that arginine can suppress Aβ aggregation both
in vitro
and
in vivo
," explains Prof. Nagai. "What makes this finding exciting is that arginine is already known to be clinically safe and inexpensive, making it a highly promising candidate for repositioning as a therapeutic option for AD."
Improved Brain Health and Reduced Inflammation
In the mouse model, the benefits went beyond reducing protein buildup. Arginine lowered amyloid plaque levels and reduced the amount of insoluble Aβ42 in the brain. Treated mice also performed better in behavioral tests.
The researchers found that arginine reduced the activity of genes linked to pro-inflammatory cytokines, which are associated with neuroinflammation, a major feature of Alzheimer's disease. This suggests that arginine may not only prevent harmful protein aggregation but also protect brain cells more broadly.
"Our findings open up new possibilities for developing arginine-based strategies for neurodegenerative diseases caused by protein misfolding and aggregation," notes Prof. Nagai. "Given its excellent safety profile and low cost, arginine could be rapidly translated to clinical trials for Alzheimer's and potentially other related disorders."
A Low-Cost Path Toward New Alzheimer's Treatments
The study highlights the growing interest in drug repositioning, which involves finding new uses for existing, well-established compounds. Because arginine is already used clinically in Japan and has been shown to safely reach the brain, it could bypass some of the early hurdles that slow down traditional drug development.
Still, the researchers caution that more work is needed. Additional preclinical and clinical studies will be required to determine whether these results can be reproduced in humans and to establish the most effective dosing strategies.
Even so, the findings provide strong early evidence that simple nutritional or pharmacological approaches may help reduce amyloid buildup and improve brain function.
Expanding Understanding of Alzheimer's Biology
Beyond its potential as a treatment, this work sheds new light on how Aβ proteins form and accumulate in the brain. It also points to a practical and cost-effective strategy that could eventually benefit millions of people living with Alzheimer's worldwide.
Professor Yoshitaka Nagai, a neurologist and Chair of the Department of Neurology at Kindai University Faculty of Medicine in Osaka, focuses his research on neurodegenerative diseases including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis. His work centers on protein misfolding and RNA-related mechanisms, and he has received multiple honors from organizations such as the Japanese Society of Neurochemistry and the Japanese Dementia Society.
This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (Grant No. 20H05927), Japan Society for the Promotion of Science (JSPS) (Grant Nos. 24H00630, 21H02840, 22H02792, and 25K02432), Japan Science and Technology Agency (JST) Super-Highway Program (SHW2023-03), and National Center of Neurology and Psychiatry.
RELATED TOPICS
Health & Medicine
Pharmacology
Immune System
Diseases and Conditions
Parkinson's Research
Mind & Brain
Consumer Behavior
Dementia
Alzheimer's
Multiple Sclerosis
RELATED TERMS
Amino acid
Protein
Alzheimer's disease
Protein biosynthesis
Genetic code
Psychology
Protein structure
Amyloid
Story Source:
Materials provided by
Kindai University
.
Note: Content may be edited for style and length.
Journal Reference
:
Kanako Fujii, Toshihide Takeuchi, Yuzo Fujino, Noriko Tanaka, Nao Fujino, Akiko Takeda, Eiko N. Minakawa, Yoshitaka Nagai.
Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer\'s disease
.
Neurochemistry International
, 2025; 191: 106082 DOI:
10.1016/j.neuint.2025.106082
Cite This Page
:
MLA
APA
Chicago
Kindai University. "This simple amino acid supplement greatly reduces Alzheimer’s damage." ScienceDaily. ScienceDaily, 4 May 2026. <www.sciencedaily.com
/
releases
/
2026
/
05
/
260504075512.htm>.
Kindai University. (2026, May 4). This simple amino acid supplement greatly reduces Alzheimer’s damage.
ScienceDaily
. Retrieved May 4, 2026 from www.sciencedaily.com
/
releases
/
2026
/
05
/
260504075512.htm
Kindai University. "This simple amino acid supplement greatly reduces Alzheimer’s damage." ScienceDaily. www.sciencedaily.com
/
releases
/
2026
/
05
/
260504075512.htm (accessed May 4, 2026).
Explore More
from ScienceDaily
RELATED STORIES
Scientists Discover Alzheimer’s Hidden “death Switch” in the Brain
Mar. 23, 2026 —
Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two ...
Scientists Discover Brain Switches That Clear Alzheimer’s Plaques
Feb. 17, 2026 —
Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels ...
This Natural Amino Acid Could Help Stop Cavities Before They Start
Jan. 9, 2026 —
Sugar-loving mouth bacteria create acids that damage teeth, but arginine can help fight back. In a clinical trial, arginine-treated dental plaque stayed less acidic, became structurally less harmful, ...
Simple Amino Acid Supplement Greatly Reduces Alzheimer’s Damage
Nov. 21, 2025 —
Researchers discovered that the common amino acid arginine can block harmful Aβ aggregation and reduce its toxic effects in Alzheimer’s disease models. In flies and mice, oral arginine lowered ...
Hidden Alzheimer’s Warning Signs Found in Parkinson’s Patients Without Dementia
Sep. 28, 2025 —
Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. ...
A Diet of Essential Amino Acids Could Keep Dementia at Bay
Oct. 22, 2021 —
Protein intake is known to be vital for maintaining brain function in older individuals. Now, using a mouse model of Alzheimer's disease, researchers have shown that the intake of a specific set ...
TRENDING AT
SCITECHDAILY.com
A Simple Molecule Could Unlock Safer, Easier Weight Loss
Researchers Unveil Groundbreaking Sustainable Solution to Vitamin B12 Deficiency
Darwin’s Islands Still Evolving: Giant Daisies Rewrite the Rules of Evolution
Beyond Inflammation: Scientists Uncover New Cause of Persistent Rheumatoid Arthritis
Â
Print
Â
Email
Â
Share
Breaking
this hour
Simple Supplement Slows Alzheimer’s
Plastic Waste Becomes Clean Energy
MIT Scientists Crack a Materials Mystery
Da Vinci Bloodline Unlocks DNA Secrets
The Truth About Creatine
Blood Test May Detect Depression
Evolution Isn’t as Random as Thought
Coffee Rewires Your Gut and Mood
A Deadly Disease Split Early Humans
The Sound You Can’t Hear May Stress You
Trending Topics
this week
HEALTH & MEDICINE
Fitness
Medical Devices
Mental Health Research
MIND & BRAIN
Intelligence
Brain-Computer Interfaces
Dementia
LIVING & WELL
Fitness
Skin Care
Healthy Aging
Strange & Offbeat
Â
HEALTH & MEDICINE
Scientists Just Discovered What Coffee Is Really Doing to Your Gut and Brain
Scientists Sound Alarm as Dangerous Amoebas Spread Globally
Scientists Discover a Hidden Brain “cleaning” Effect Triggered by Movement
MIND & BRAIN
The Creepy Feeling in Old Buildings Might Have a Surprising Cause
Are Your Memories Real? Physicists Revisit the Boltzmann Brain Paradox
This AI Knew the Answers but Didn’t Understand the Questions
LIVING & WELL
Scientists Discover How to Freeze Transplant Organs Without Cracking Them
This One Change to Your Exercise Routine Could Add Years to Your Life
Harvard Scientists Link Gut Bacteria to Depression Through Hidden Inflammation Trigger